Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Driving fitness study of Silexan versus placebo and lorazepam in healthy volunteers
2015-001101-14Phase 2Completed
- Sponsor
- Schwabe Group
- Start
- Jan 2016
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Silexan in anxiety disorder (6 arms), sponsored by Schwabe Group. Primary endpoint: Standard Deviation of Lane Position during the vigilance section of the driving test. Started Jan 2016; status: completed.
02
Drugs
Silexan
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on 2015-001101-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001101-14.